Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Rethinking the immune recognition of cell walls in human fungal pathogens: Mechanisms, controversies and translational significance.

Created on 14 Sep 2026

Authors

Rong Wang, Xiaoyu Peng, Wenqing Liu, Zhangyong Song, Hong Yu

Published in

Virulence. Volume 17. Issue 1. Pages 2719264. Epub Sep 14, 2026.

Abstract

Fungal cell wall polysaccharides - such as β-glucans, chitin, and mannans - are key immunogenic structures recognized by Toll-like receptors and C-type lectin receptors on innate immune cells, initiating phagocytosis, cytokine production, and antigen presentation, and shaping downstream adaptive immunity. CD4+ T cells differentiate into Th1, Th2, Th17, and Treg subsets to maintain immune balance, whereas B cells contribute to fungal clearance and memory through species-specific antibodies. The boundary between protective and pathogenic immunity varies with fungal species, infection stage, and host immune status, collectively influencing PRR signaling and lymphocyte effector outcomes. This review summarizes recognition mechanisms, signaling pathways, and immunoregulatory roles of immune cells in response to fungal cell wall polysaccharides, highlighting the dual roles of innate and adaptive immunity in antifungal defense and immunopathology, and discussing current controversies, knowledge gaps, and prospects for immunomodulatory and vaccine-based antifungal strategies.

PMID:
42734204
Bibliographic data and abstract were imported from PubMed on 14 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement